Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma.

Sci Rep · 2021 · PMC8119955 · PMID 33986386

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

4 A, MTT assays after sunitinib treatment demonstrated that tumor cell growth was inhibited by sunitinib in all RCC cells (RCC-24, 786-O, and Caki-2) and normal HEK 293-T cells in a dose-dependent manner while KTZ did not show a significant trend.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.